Skip to main content
. 2021 Nov 22;10(22):5444. doi: 10.3390/jcm10225444

Table 4.

Characteristics at admission and at failure time of patients that failed CPAP + NIV treatment and were intubated vs. patients that succeeded CPAP + NIV.

CPAP + ETI (n = 18) CPAP + NIV + ETI (n = 29) p-Value
Males, n (%) 15 (83.3) 27 (93.1) 0.279
Age, years 60.5 (57.7–65) 57 (50.5–63.5) 0.047
Days from symptoms onset to hospital admission 8 (6–11) 8 (5–9) 0.722
Comorbidities
Previous respiratory disease, n (%) 2 (11.1) 2 (6.9) 0.498
Smoke, n (%) 1 (5.9) 1 (3.4) 0.608
Hypertension, n (%) 9 (50.0) 6 (20.7) 0.039
Diabetes, n (%) 2 (11.1) 2 (6.9) 0.498
Ischemic heart disease, n (%) 3 (16.7) 2 (6.9) 0.279
Sartan, n (%) 3 (17.6) 1 (3.4) 0.135
ACE inhibitors, n (%) 2 (11.8) 0 (0) 0.131
Emergency department
White blood cells, ×106 9.2 (3.1) 7.2 (2.6) 0.106
Neutrophils, % 85.2 (82.5–90.5) 76.9 (69.7–83.8) 0.003
Lymphocytes, % 8.5 (5.4–12.5) 14.2 (9.1–21.2) 0.008
Platelets, ×109 271.0 (159.9) 201.2 (58.9) 0.039
I.N.R. 1.4 (1.2–1.6) 1.1 (1.1–1.2) <0.001
Bilirubin, mg/dL 1.19 (0.91–1.84) 0.73 (0.47–1.02) 0.005
Serum creatinine, mg/dL 1.0 (0.7–1.2) 1.0 (0.9–1.1) 0.963
Lactate dehydrogenase, U/L 602 (430–725) 316 (233–465) 0.001
D-dimer, mg/L FEU 2885 (334–27,899) 314 (186–468) 0.062
Respiratory rate, bpm 25.0 (23–30) 24.0 (22–30) 0.674
pH 7.48 (7.46–7.51) 7.47 (7.44–7.49) 0.192
PaCO2, mm/Hg 35.5 (4.6) 31.8 (4.9) 0.053
PaO2/FiO2, mm/Hg 173 (89–268) 253 (190–319) 0.003
At CPAP or NIV failure
Lymphocytes, % 5.5 (3.0–6.6) 8.2 (6.1–14.0) 0.03
Platelets, ×109 270.6 (105.5) 318.2 (124.4) 0.29
I.N.R. 1.3 (1.2–1.7) 1.2 (1.1–1.3) 0.15
Bilirubin, mg/dL 1.19 (0.97–1.28) 0.76 (0.46–1.03) 0.05
Serum creatinine, mg/dL 0.7 (0.6–0.8) 0.7 (0.6–0.8) 0.84
D-dimer, mg/L FEU 1577 (381–5200) 826 (276–2570) 0.52
Respiratory rate, bpm 33.5 (24–42) 29.5 (26–30) 0.06
pH 7.46 (0.04) 7.48 (0.04) 0.19
PaCO2, mmHg 39 (4.5) 36.8 (5.0) 0.15
PaO2/FiO2, mmHg 99 (82–112) 110 (86–150) 0.34
Outcomes
Length of hospital stay, days 19 (14.5–25.0) 27.8 (17–39) 0.162
In hospital mortality, n (%) 14 (77.8) 13 (44.8) 0.026

Data are reported as means (standard deviation) or medians (interquartile range), as appropriate. Statistically significant comparisons are marked in bold. ACE = angiotensin converting enzyme; Hb = hemoglobin; PaO2 = partial pressure of oxygen; PaCO2 = partial pressure of carbon dioxide; FiO2 = inspired oxygen fraction.